Log­icBio guns for $75M IPO; Alexan­dria lands a new biotech build­ing on Long Is­land

→ Pro­lif­ic life-sci­ence de­vel­op­er Alexan­dria Re­al Es­tate Eq­ui­ties just plopped down $75M for a build­ing in Long Is­land City fresh off the heels of its pur­chase of Pfiz­er HQ in Man­hat­tan ear­li­er this year.

→ Cam­bridge-based Log­icBio is aim­ing for a $75 mil­lion haul dur­ing its IPO run. The gene edit­ing com­pa­ny is look­ing to beef up its cof­fers for a Phase I/II run on methyl­malonic acidemia (MMA). It will list un­der $LOGC on Nas­daq.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER